Autek China Inc.

SZSE:300595 Voorraadrapport

Marktkapitalisatie: CN¥18.6b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Autek China Inkomsten in het verleden

Verleden criteriumcontroles 3/6

Autek China has been growing earnings at an average annual rate of 18%, while the Medical Equipment industry saw earnings growing at 5.2% annually. Revenues have been growing at an average rate of 22.9% per year. Autek China's return on equity is 15.2%, and it has net margins of 37%.

Belangrijke informatie

18.0%

Groei van de winst

16.6%

Groei van de winst per aandeel

Medical Equipment Groei van de industrie16.0%
Inkomstengroei22.9%
Rendement op eigen vermogen15.2%
Nettomarge37.0%
Volgende winstupdate26 Oct 2024

Recente prestatie-updates uit het verleden

Recent updates

Autek China Inc.'s (SZSE:300595) Shares Climb 44% But Its Business Is Yet to Catch Up

Sep 30
Autek China Inc.'s (SZSE:300595) Shares Climb 44% But Its Business Is Yet to Catch Up

Autek China Inc. (SZSE:300595) Shares Could Be 49% Below Their Intrinsic Value Estimate

Sep 01
Autek China Inc. (SZSE:300595) Shares Could Be 49% Below Their Intrinsic Value Estimate

Little Excitement Around Autek China Inc.'s (SZSE:300595) Earnings

Aug 14
Little Excitement Around Autek China Inc.'s (SZSE:300595) Earnings

Be Wary Of Autek China (SZSE:300595) And Its Returns On Capital

Jul 04
Be Wary Of Autek China (SZSE:300595) And Its Returns On Capital

Autek China (SZSE:300595) Has Announced That It Will Be Increasing Its Dividend To CN¥0.223

May 14
Autek China (SZSE:300595) Has Announced That It Will Be Increasing Its Dividend To CN¥0.223

We Think Autek China (SZSE:300595) Can Manage Its Debt With Ease

Apr 16
We Think Autek China (SZSE:300595) Can Manage Its Debt With Ease

An Intrinsic Calculation For Autek China Inc. (SZSE:300595) Suggests It's 28% Undervalued

Mar 22
An Intrinsic Calculation For Autek China Inc. (SZSE:300595) Suggests It's 28% Undervalued

Autek China Inc.'s (SZSE:300595) 25% Price Boost Is Out Of Tune With Earnings

Mar 04
Autek China Inc.'s (SZSE:300595) 25% Price Boost Is Out Of Tune With Earnings

There Are Reasons To Feel Uneasy About Autek China's (SZSE:300595) Returns On Capital

Mar 01
There Are Reasons To Feel Uneasy About Autek China's (SZSE:300595) Returns On Capital

Opbrengsten en kosten

Hoe Autek China geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

SZSE:300595 Opbrengsten, kosten en inkomsten (CNY Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 241,84068055041
31 Mar 241,80068652641
31 Dec 231,73766749940
30 Sep 231,63465746939
30 Jun 231,62167644336
31 Mar 231,55664942433
01 Jan 231,52562443034
30 Sep 221,51061741632
30 Jun 221,40955739231
31 Mar 221,37956537429
01 Jan 221,29555535127
30 Sep 211,26059932826
30 Jun 211,14456129724
31 Mar 211,05453327422
31 Dec 2087143323819
30 Sep 2076935521819
30 Jun 2068131820718
31 Mar 2063029419617
31 Dec 1964730719416
30 Sep 1961328018716
30 Jun 1954724916615
31 Mar 1950223114913
31 Dec 1845821612413
30 Sep 184192049912
30 Jun 183661768115
31 Mar 183311606613
31 Dec 173121516210
30 Sep 17288140496
30 Jun 17258124480
31 Mar 17249122480
31 Dec 16235114460
31 Dec 1517689380
31 Dec 1413064310
31 Dec 139125410

Kwaliteitswinsten: 300595 has high quality earnings.

Groeiende winstmarge: 300595's current net profit margins (37%) are lower than last year (41.7%).


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: 300595's earnings have grown by 18% per year over the past 5 years.

Versnelling van de groei: 300595's earnings growth over the past year (0.6%) is below its 5-year average (18% per year).

Winst versus industrie: 300595 earnings growth over the past year (0.6%) exceeded the Medical Equipment industry -8.6%.


Rendement op eigen vermogen

Hoge ROE: 300595's Return on Equity (15.2%) is considered low.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden